🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
38.93
-1.26 (-3.14%)
At close: Nov 19, 2026, 4:00 PM EST
38.75
-0.18 (-0.46%)
After-hours: Nov 19, 2026, 5:37 PM EST

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG had revenue of $12.67M in the quarter ending September 30, 2026, with 1,325.08% growth. This brings the company's total for the last twelve months to $25.17M, down -34.34% year-over-year. In the year 2025, CRISPR Therapeutics AG had annual revenue of $3.51M, down -90.59%. That makes CRISPR Therapeutics AG the 32,492nd largest company in the world by revenue and 4,264th in the United States.

Revenue (ttm)
$25.17M
Revenue Growth
-34.34%
P/S Ratio
153.76
Revenue / Employee
$64,051
Employees
393
Market Cap
3.78B

Revenue Chart

Revenue by Segment

  • Collaboration 35.00M 93.8%
  • Grant 2.31M 6.2%
Fiscal year ended Dec 31, 2024 See the full CRISPR Therapeutics AG breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.51M-33.80M-90.59%
Dec 31, 202437.31M-333.89M-89.95%
Dec 31, 2023371.21M370.01M30,885.48%
Dec 31, 20221.20M-913.77M-99.87%
Dec 31, 2021914.96M914.24M127,154.94%
Dec 31, 2020719.00K-288.87M-99.75%
Dec 31, 2019289.59M286.47M9,169.85%
Dec 31, 20183.12M-37.87M-92.38%
Dec 31, 201741.00M35.83M693.90%
Dec 31, 20165.16M4.92M1,990.69%
Dec 31, 2015247.00K--
Dec 31, 2014---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.